SIX1 expression and its clinicopathological significance: difference between classic and follicular variant papillary thyroid carcinoma
Elzahraa Ibrahim Khalil, Ahmed S Issa, Rehab M Kamal · 2024
Read SIX1 expression and its clinicopathological significance: difference between classic and follicular variant papillary thyroid carcinoma by Elzahraa Ibrahim Khalil, Ahmed S Issa, Rehab M Kamal (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11626750.txt.
Description
Khalil, Issa, and Kamal measured a developmental gene's protein in thyroid tumors in twenty twenty-four. Papillary thyroid carcinoma is the commonest thyroid cancer and usually curable, yet about ten percent of patients die within ten years, mainly from spread to neck lymph nodes. The SIX1 protein helps build tissues in the embryo and may mark aggressive tumors.
Using antibody staining on one hundred twenty-five tumors, the team compared the classic subtype with the follicular variant. High SIX1 levels tracked with larger tumors, multiple tumor foci, lymph node spread, higher grade and stage, and invasion beyond the thyroid. The exact partners differed by subtype: size and grade in classic tumors, nodal spread and invasion in the variant. The authors propose SIX1 as a prognostic marker guiding subtype-specific strategies.
Catalog record
| CREATOR | Elzahraa Ibrahim Khalil, Ahmed S Issa, Rehab M Kamal |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 30 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |